C8B
C8B is the beta subunit of complement component 8, one of the proteins that build the membrane attack complex (MAC) of the complement system. The C8B gene encodes a secreted protein that helps the MAC insert into target cell membranes. Browse Assay Genie's current range of C8B research reagents below, or read on for the biology behind the target.
C8B is a component of the membrane attack complex (MAC), a multiprotein complex activated by the complement cascade. The MAC inserts into a target cell membrane and forms a pore, leading to membrane rupture and cell lysis. Assembly is initiated when C5 is proteolytically cleaved into C5b in response to the classical, alternative, lectin and GZMK complement pathways. These pathways form a cascade that leads to phagocytosis and breakdown of pathogens, and to signalling that strengthens the adaptive immune system.
Within the MAC, C8B acts together with C8A and C8G. This group inserts into the target membrane but does not form pores by itself. During assembly, C8 associates with C5b, C6 and C7 to form the C5b8 intermediate complex, which inserts into the membrane and traverses the bilayer, increasing membrane rigidity. NCBI Gene notes that C8B mediates the interaction of C8 with the C5b-7 MAC precursor, and that C8 initiates membrane penetration by the complex.
The C8B gene encodes one of three subunits of the complement component 8 (C8) protein. C8 consists of equimolar amounts of alpha, beta and gamma subunits, each encoded by a separate gene. The protein belongs to the complement C6/C7/C8/C9 family, and HGNC places the gene in the groups for complement system activation components and the membrane attack complex. It was previously named complement component 8, beta polypeptide. Alternative splicing produces multiple transcript variants. In humans, C8B deficiency is associated with an increased risk of meningococcal infection.
C8B is a component of the complement cascade, which drives pathogen breakdown and signalling that strengthens adaptive immunity.
C8B joins C5b, C6 and C7 to form the C5b8 intermediate that inserts into and crosses the target membrane.
Human C8B deficiency is associated with increased risk of meningococcal infection, linking the gene to host defence against bacteria.
As part of the MAC, C8B contributes to membrane penetration that leads to pore formation, membrane rupture and target cell lysis.
C8B is the beta subunit of complement component 8 and part of the membrane attack complex. With C8A and C8G it inserts into the target membrane, though not forming pores alone. It also mediates the interaction of C8 with the C5b-7 precursor, helping the MAC lyse target cells.
The approved HGNC name is complement C8 beta chain, and UniProt calls it complement component C8 beta chain. The previous HGNC name was complement component 8, beta polypeptide. No other aliases are listed. Alternative splicing gives multiple transcript variants of the C8B gene.
Mouse and rat both have a C8b ortholog. In humans, C8B deficiency is associated with an increased risk of meningococcal infections. Check the datasheet of any product for its validated reactivity.
Other membrane attack complex subunits and complement components that act alongside C8B in the complement cascade.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P07358; product specifications from Assay Genie datasheets.